Download
1 / 19
190 likes | 304 Views
A 6-gene signature for outcome prediction of grade II/III glioma<br />. Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting. Learning Objectives. Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting. Outline. Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting.
E N D
A 6-gene signature for outcome prediction of grade II/III glioma<br /> Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Learning Objectives Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Outline Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Introduction<br />Survival of grade II/III glioma Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Methods – identification of genes Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Methods – model building Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Methods – analysis Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Discovery cohorts Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Validation cohorts Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Results Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
TCGA GBM (new cases) Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Slide 12 Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Slide 13 Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
OS of TCGA LGG<br />grade II/III patients Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Slide 15 Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
3 year OS ROC Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Top right: 7 year OS probability Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Conclusion Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
Acknowledgments Presented By Tim Lautenschlaeger at 2014 ASCO Annual Meeting
